Form 4: Edwards Lifesciences Executive Daveen Chopra Reports Stock Disposal

Daveen Chopra, CVP of TMTT at Edwards Lifesciences, reported the disposal of 821 shares of common stock on May 11, 2024.

Summary

• On May 11, 2024, Daveen Chopra, CVP, TMTT of Edwards Lifesciences Corp, disposed of 821 shares of common stock.
• The transaction was executed at a price of $86.72 per share.
• Following the transaction, Chopra directly owns 30,583 shares of Edwards Lifesciences Corp.
• This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Sentiment

Score: 5

Explanation: This is a routine disclosure of stock disposal, with no inherent positive or negative sentiment. It simply reflects a transaction by an executive.

Industry Context

Form 4 filings are a routine part of insider trading disclosures, providing transparency into the transactions of company executives and directors. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The transaction may have a minor impact on shareholders as it provides insight into an executive's stock activity.

Key Dates